Orvieto R, Kerner R, Krissi H, Ashkenazi J, Ben Rafael Z, Bar-Hava I. Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study.
Fertil Steril 2002;
78:1268-71. [PMID:
12477523 DOI:
10.1016/s0015-0282(02)04262-0]
[Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
OBJECTIVE
To compare the use of two depot GnRH-a, leuprolide and triptorelin, in long-suppression GnRH-a protocols.
DESIGN
Prospective, randomized study.
SETTING
An IVF unit of an academic medical center.Fifty-two women who underwent controlled ovarian hyperstimulation and IVF.
INTERVENTION(S)
Patients were prospectively randomized to receive 3.75 mg depot formulations of either leuprolide or triptorelin on days 21-23 of the menstrual cycle. Stimulation with gonadotropins was initiated after pituitary desensitization was achieved.
MAIN OUTCOME MEASURE(S)
The stimulation pattern and cycle outcomes were compared between the two groups.
RESULT(S)
Twenty-six patients were included in each group. No significant differences were observed in the patient age, estrogen, and P levels on day of hCG administration, gonadotropin dosage, number of oocytes retrieved, fertilization rate, percentage of high-quality embryos, and number of embryos transferred. However, significantly higher clinical implantation and pregnancy rates were found in the leuprolide group compared with the triptorelin group.
CONCLUSION(S)
A depot preparation of leuprolide is associated with higher implantation and pregnancy rates than a depot preparation of triptorelin when it is used in the midluteal phase as part of the long-suppression GnRH-a protocol in IVF.
Collapse